

** 1 ** Table 4.2 AMENDMENT No. 1 TO THE CONVENTION ON ACTIONS AND ACTIVES

This first amendment to the agreement to purchase shares and assets, dated December 27, 2013 (the "first amendment"), is concluded by and between Novartis Vaccines and Diagnostics, Inc., a Delaware company ("Seller"), Novartis Corporation, a New Vork company, as guarantor, G-C Diagnostics Corp., a Delaware company ("Buyer"), and Grifols, S.A., a company (sociedad an√¥nima) incorporated under Spanish laws, as guarantor.

CONSIDERANTS

WHEREAS the parties herein are parties to this agreement to purchase shares and assets dated November 10, 2013 (the "original agreement") and wish to amend and amend certain terms and conditions of the original agreement as specified in this amendment; and

WHEREAS Article 10.10 of the original Agreement requires that any amendment or amendment to the original Agreement be made in writing and signed by the buyer and the seller;

NOW, IN CONSEQUENTLY, having regard to the following mutual commitments and agreements and for any other valid and valid consideration, the receipt and sufficiency of which are hereby recognized, the Parties hereby agree that:

DEFINITIONS OF ARTICLE I

The terms beginning with capital letters used but not otherwise defined in this First Amendment shall have the meaning indicated in the Initial Agreement.

ARTICLE II APPLICABLE DATE OF THE ROLLING FUND

The definition of "Applicable Working Capital Date" in Article I of the Initial Agreement is amended and redrafted as follows:

"Applicable working capital date" means (1) if the closure occurs on or before January 10, 2014, December 31, 2013, and (ii) if the closure occurs after January 10, 2014, the closing date."

ARTICLE I CLOSING

Section 3.01 of the original Agreement is amended and redrafted as follows:

"Subject to the terms of this Agreement, the completion of the transactions contemplated by this Agreement (the "closure") shall take place at the offices of Xxxxx & Xxxxx LLP, 0000 xxxxxx xx xxx Xxxxxx, Xxx XXXX, XXX Xxxx 00000, commencing at 3:00 p.m. Eastern Standard Time, January 9, 2014; however, if all of the closing conditions set out in Article VII are not met or are not waived (other than the conditions which, by their nature, are to be met on the closing date) by January 9, 2014, /the close shall take place on the last calendar day of the month in which all of the closing conditions set out in Article VII are met or lifted (other than the closing conditions which, by their nature, must be met) by January 9, 2014, /the close shall take place on the last calendar day of the month in which all of the closing conditions set out in Article VIT are met or waived (other than the closing conditions which, by their nature, are to be

I'm sorry, but I don't know.

If the closing date is to take place on January 9, 2014, the documents to be filed at the closing date in accordance with article 3.02 shall be kept under receivership pending receipt by the seller of the amount payable by the buyer in accordance with article 2.07(a). If the closing date is January 9, 2014, the documents to be filed at the closing date shall be released from receipt and the closing date shall be deemed to have taken place on January 9, 2014. If the closing date is not received by the seller before January 10, 2014, the documents to be issued at the closing date shall be released from disposal on January 10, 2014, and the closing date shall be deemed to have taken place on January 10, 2014. ** 2 ** ARTICLE IV TRANSMITMENT AND PRESENTATION AGREEMENTS

1.The definition of "assignment and assumption agreement" in Article 1 of the original agreement is amended and redrafted as follows:

"A transfer and take-over agreement" means a transfer and take-over agreement essentially in the form set out in Annex A, or alternatively, another agreement agreed between the Seller and the Purchaser carrying out the transfer and take-over by the Purchaser or one of its Affiliates of the Purchased Assets and of the Covered Liabilities (each of these Alternative Agreements, a "Local Transfer Agreement").

2.Article 1 of the original Agreement is amended by adding the following definition in the appropriate alphabetical heading:

"Local Transfer Agreement" has the meaning given to it in the definition of "Transfer and Takeover Agreement".

3. Article 3.02(a)(i) of the original Agreement is amended and redrafted as follows:

"(i) one or more transfer and assumption agreements duly signed by the seller or an affiliate of the seller, collectively transferring and taking over by the buyer and its affiliates all the assets purchased and all the liabilities assumed other than the assets purchased and the liabilities assumed that will be transferred to the buyer or its affiliates in accordance with other transaction documents;"

4. Section 6.25 of the original Agreement is amended by adding the following at the end of that section:

"Each local transfer agreement shall be subject to and governed by the terms and conditions of this Agreement, mutatis mutandis, in all respects (including, without limitation, Article VII). In the event of conflict or inconsistency between the terms of this Agreement and any local transfer agreement, the terms of this Agreement shall prevail. In order to avoid any ambiguity, with respect to each local transfer agreement, the consideration (as defined in this local transfer agreement) for assets purchased under this Agreement shall be included in the purchase price below and shall be payable under (and not added to) the local transfer agreement.

I'm sorry, but I don't know.

ARTICLE V FRENCH CONTRACT

Notwithstanding any provision contrary to Article 6.09(e) of the original Contract, Annex 6.09(e) of the original Contract or any other provision of the original Contract, the Seller and the Buyer hereby agree that the Seller shall have no obligation to transfer, obtain or use any effort to obtain consent with respect to: the French Contract.

ARTICLE VI CONDITIONS CONCERNING THE OBLIGATIONS OF THE BUYER

1. Article 7.02(a) of the original Agreement is amended and redrafted as follows:

(a) With the exception of the declarations and warranties of the Seller contained in section 4.01(a), article 4.02, article 4.04, article 4.08(a) and article 4.22 (collectively, the "Seller's Fundamental Declarations") and article 4.06(b)), the Seller's declarations and warranties contained in this Agreement and other Transaction Agreements must be true and correct (without giving effect to any qualification as to the materiality or material adverse effect set out herein and herein) from (1) if the closing date is on or before January 10, 2014, December 31, 2013 (as if, for the purposes of this Article 7.02(a), the transactions contemplated herein and are therefore consumed on or after December 31, 2013 or (ii) if the closing date is after January 10, 2014, the closing date, with the same effect as if the closing date had been made on or after January 10, 2014 (as if, for the purposes of this Article 7.02(a), the transactions contemplated herein and are therefore consumed on or after December 31, 2013 are to be determined as to the actuality of the specified date, and (if, for the specified date, the closing date, the closing date, with the same effect as if, the closing date as if, the closing date of the closing date, with the closing date of the closing date of the closing date of the closing date of the closing date of the closing date of the closing date of the closing date of the closing of the closing of the closing of the closing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing of the filing

2. Article 7.02(c) of the original Agreement is amended and redrafted as follows:

(c) The consents to the collaborative agreement shall be fully in force and have full effect from (1) if the closure takes place no later than January 10, 2014, December 31, 2013, or (ii) if the closure takes place after January 10, 2014, the closing date; provided that a consent to the signed and remitted collaborative agreement which has not been revoked in writing by the counterparty constitutes prima facie evidence that such consent to the collaborative agreement has been obtained and is fully in force."

3. Article 7.02(d) of the original Agreement is amended and redrafted as follows:

(d) From the date of this Agreement until (i) if the closure takes place no later than January 10, 2014, December 31, 2013 (as if, for the purposes of this Section 7.02 (d)), the transactions envisaged in this Agreement and other transaction agreements were consumed on

December 31, 2013 or (ii) if the closure occurs after January 10, 2014, the closing date, no significant adverse effect shall have occurred and continue.

4. Article 8.02(a) of the original Agreement is amended and redrafted as follows:

I'm sorry, but I don't know.

"(a) any inaccuracy or breach of any of the Seller's declarations or warranties contained in this Agreement or any other Transaction Agreement, as of the date of this Agreement and as of (i) if the Closing is on or before January 10, 2014, December 31, 2013 (as if, for the purposes of this Article 8.02(a), the transactions contemplated by this Agreement and any other Transaction Agreement are consumed on or after December 31, 2013) or (ii) if the Closing is after January 10, 2014, the Closing Date (with the exception of any declarations and warranties expressly relating to a specified date, the Inaccuracy or Violation of which shall be determined by reference to that specified date);

OPINION UNDER ARTICLE VII

1. Article 10.03 of the Original Contract is hereby amended by deleting the address indicated for "Buyer or Grifols" and replacing it with the following:

Grifols, S.A. x/X XXXXXXXXX XXXXXXX XXXXX XXXXXX XxXX 00000 fax: x0 (000) 000-0000

to the attention of: XXxxxx x.

XXXXXXX

Xxxxx X. XXXXXXXX

2. Article 10.03 of the original Agreement is hereby amended by deleting the requirement that a copy of each communication sent to the Buyer or Grifols be sent to the following address:

XXXXXXXXX XXXX XXXX XXXXXX XXXXXX XXXXXX XXXXX, XXX XXXX OO000 Fax: x0 (000) 000-0000 Attention: XXXXX X. XXXXXXX

Xxxxxxx X. XXXXXXXX ** 4 ** ARTICLE VIII RELATIONSHIP WITH INITIAL AGREEMENT

Except where amended and amended, all provisions of the original Agreement shall remain fully in force and, as amended and amended, shall be ratified and reaffirmed. This first amendment shall be subject to the applicable general conditions of the original Agreement, and shall be interpreted with and be an integral part of it. As from the date of this First Amendment, all references in the original Agreement to this Agreement shall be deemed to be references to the original Agreement as amended and hereby amended.

COMPETITIONS UNDER ARTICLE IX

This first amendment may be carried out in consideration, each of which shall be considered as an original, but which together shall be considered as a single agreement. A signed copy of this First Amendment submitted by fax, e-mail or any other means of electronic transmission shall be deemed to have the same legal effect as the delivery of an original signed copy of this First Amendment.

I'm sorry, but I don't know.

IN WITNESS WHEREOF, the Parties hereto have enforced this First Amendment on the date indicated above by their respective officials duly authorized.

NOVARTIS VACCINES AND DIAGNOSTICS, INC.

By: /8/ XXXXXXXX XXXXX Name: xxxxxxx XXXXX Title As a lawyer

G-C DIAGNOSTICS CORP.

By: 1s/ xxxxxx xxxx Name: xxxxxx xxxx Title Board Member

NOVARTIS CORPORATION

By 1$/ XXXXXXXX XXXXX Name: xxxxxxx xXXXxXX Title: As Attorney

GRIFOLS, S.A.

By 1$/ XXXxXx XXXX Name: xxxx xxxx Title: Board Member

I'm sorry, but I don't know.